MinuteCE®
A robust collection of short-form, digestible CE activities that are made to fit into any schedule. With MinuteCE, you’re in control of the content you want, when you want it. To start microlearning, follow these simple steps:
Step 1: Select the episodes & 1-minute challenges you'd like to consume
Step 2: Bank time as you blaze your way through the program
Step 3: Claim credit once available as shown in the Progress Bar
Step 4: Track the status of credits claimed in your profile
Why choose microlearning?
- Bite-sized episodes
- The most relevant content
- Improved retention
To experience MinuteCE for yourself, select one of the episodes below to start learning!
76-90 of 168
Implementing CIDP Clinical Guidelines: Optimizing Therapy
MinuteCE®Implementing CIDP Clinical Guidelines: Optimizing Therapy
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
MinuteCE®CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
MinuteCE®Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
MinuteCE®Autoantibodies in CIDP: Prevalence and Diagnostic Implications
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
MinuteCE®Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
- advertisement
Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
MinuteCE®Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
Decoding CIDP: Exploring Common and Atypical Variants
MinuteCE®Decoding CIDP: Exploring Common and Atypical Variants
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
Case Application: Adverse Event Management of Patients With EGFRm Resistance Treated With Novel HER3-Directed ADCs
MinuteCE®Case Application: Adverse Event Management of Patients With EGFRm Resistance Treated With Novel HER3-Directed ADCs
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
MinuteCE®Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
MinuteCE®Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
- advertisement
Overcoming EGFR Resistance With HER3-Directed ADCs
MinuteCE®Overcoming EGFR Resistance With HER3-Directed ADCs
Helena Yu, MD
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
MinuteCE®Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
